172 related articles for article (PubMed ID: 10560433)
21. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
23. [Intra-arterial infusion chemotherapy with [Sar1, Ile8] angiotensin II in bladder cancer].
Morita T; Kikuchi T; Hara Y; Ishikawa S; Kobayashi Y; Ishiyama S; Tozuka K; Goto K; Nakashima N; Takahashi K
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3417-22. PubMed ID: 2802636
[TBL] [Abstract][Full Text] [Related]
24. [A case of complete response was achieved with arterial infusion chemotherapy including CDDP, etoposide and pirarubicin].
Uekado Y; Watanabe T; Touge H; Inagaki T
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1075-7. PubMed ID: 8512337
[TBL] [Abstract][Full Text] [Related]
25. [Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
Maruyama T; Kondoh N; Nojima M; Yamamoto S; Mori Y; Shima H; Kamikonnya N; Hirota S; Nakao N
Hinyokika Kiyo; 2006 Jun; 52(6):445-9. PubMed ID: 16848358
[TBL] [Abstract][Full Text] [Related]
26. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
27. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
[TBL] [Abstract][Full Text] [Related]
28. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
[TBL] [Abstract][Full Text] [Related]
29. Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy.
Miyanaga N; Akaza H; Hinotsu S; Joraku A; Oikawa T; Sekido N; Kawai K; Shimazui T
Jpn J Clin Oncol; 2007 Nov; 37(11):852-7. PubMed ID: 17965422
[TBL] [Abstract][Full Text] [Related]
30. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Koukourakis MI; Tsolos C; Touloupidis S
Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
Sawada Y; Takeuchi Y; Iwasawa T; Kuroda K; Matsushima M; Nagamoto M; Wakayama M
Int J Urol; 2006 Dec; 13(12):1470-4. PubMed ID: 17118019
[TBL] [Abstract][Full Text] [Related]
32. [Intra-arterial infusion chemotherapy of advanced bladder cancer].
Akiyama M; Inoue Y; Yokota K; Sumiyoshi Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1705-8. PubMed ID: 1530337
[TBL] [Abstract][Full Text] [Related]
33. Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2009 Jun; 39(6):381-6. PubMed ID: 19351661
[TBL] [Abstract][Full Text] [Related]
34. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN
Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752
[No Abstract] [Full Text] [Related]
35. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525
[TBL] [Abstract][Full Text] [Related]
36. [Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
Ogihara M; Aikawa K; Ishibashi K; Yamaguchi O; Shiraiwa Y; Koseki K
Hinyokika Kiyo; 1997 Aug; 43(8):555-60. PubMed ID: 9310777
[TBL] [Abstract][Full Text] [Related]
37. [Intra-arterial infusion chemotherapy for superficial bladder cancer].
Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
Hinyokika Kiyo; 1999 Sep; 45(9):605-7. PubMed ID: 10540704
[TBL] [Abstract][Full Text] [Related]
38. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
[TBL] [Abstract][Full Text] [Related]
39. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
Logothetis CJ; Samuels ML; Selig DE; Wallace S; Johnson DE
Cancer Treat Rep; 1985 Jan; 69(1):33-8. PubMed ID: 2981619
[TBL] [Abstract][Full Text] [Related]
40. [The long-term prognosis of intra-arterial chemotherapy in invasive bladder cancer].
Miyanaga N; Noguchi R; Ohtani M; Kanoh S; Koiso K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2949-52. PubMed ID: 2782901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
